Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD70 CAR-T in Advanced/Metastatic Solid Tumors
NCT05947487Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD70 CAR-T cells in solid tumor, sponsored by Chinese PLA General Hospital. Started Jul 2023; status: recruiting.
02
Drugs
CD70 CAR-T cells
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05947487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947487.